AU2002214132A1 - Vector system for transducing the positive neurons - Google Patents

Vector system for transducing the positive neurons

Info

Publication number
AU2002214132A1
AU2002214132A1 AU2002214132A AU1413202A AU2002214132A1 AU 2002214132 A1 AU2002214132 A1 AU 2002214132A1 AU 2002214132 A AU2002214132 A AU 2002214132A AU 1413202 A AU1413202 A AU 1413202A AU 2002214132 A1 AU2002214132 A1 AU 2002214132A1
Authority
AU
Australia
Prior art keywords
transducing
vector system
positive neurons
neurons
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214132A
Other languages
English (en)
Inventor
Mimoun Azzouz
Nicholas Mazarakis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026943A external-priority patent/GB0026943D0/en
Priority claimed from GB0102339A external-priority patent/GB0102339D0/en
Priority claimed from GB0122238A external-priority patent/GB0122238D0/en
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Publication of AU2002214132A1 publication Critical patent/AU2002214132A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00Vectors comprising a targeting moiety
    • C12N2810/50Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C12N2810/6072Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
    • C12N2810/6081Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AU2002214132A 2000-11-03 2001-11-02 Vector system for transducing the positive neurons Abandoned AU2002214132A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0026943.1 2000-11-03
GB0026943A GB0026943D0 (en) 2000-11-03 2000-11-03 Vector system
GB0102339A GB0102339D0 (en) 2001-01-30 2001-01-30 Vector system
GB0102339.9 2001-01-30
GB0122238.9 2001-09-14
GB0122238A GB0122238D0 (en) 2001-09-14 2001-09-14 Vector system
PCT/GB2001/004866 WO2002036170A2 (en) 2000-11-03 2001-11-02 Vector system for transducing the positive neurons

Publications (1)

Publication Number Publication Date
AU2002214132A1 true AU2002214132A1 (en) 2002-05-15

Family

ID=27255961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214132A Abandoned AU2002214132A1 (en) 2000-11-03 2001-11-02 Vector system for transducing the positive neurons

Country Status (5)

Country Link
US (1) US20040071675A1 (https=)
EP (1) EP1333863A2 (https=)
JP (2) JP2004517057A (https=)
AU (1) AU2002214132A1 (https=)
WO (1) WO2002036170A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003025188A1 (en) * 2001-09-14 2003-03-27 Oxford Biomedica (Uk) Limited Use of a lentiviral vector in the treatment of pain
FR2841246B1 (fr) * 2002-06-20 2004-12-31 Centre Nat Rech Scient Peptide issu de la proteine g du virus de la rage, ligand du recepteur de basse affinite des neurotrophines(p75ntr) et ses applications
JP2006502240A (ja) * 2002-10-04 2006-01-19 オックスフォード バイオメディカ (ユーケー) リミテッド ベクター系
CA2943039C (en) 2005-10-14 2018-11-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rabies virus compositions and methods
EP2239330A1 (en) 2009-04-07 2010-10-13 Institut Pasteur Neuron generation, regeneration and protection
JP5123922B2 (ja) * 2009-12-02 2013-01-23 独立行政法人科学技術振興機構 融合糖タンパク質から成るエンベロープを有する逆行性輸送ウィルスベクター系
JP5216072B2 (ja) * 2010-11-26 2013-06-19 独立行政法人科学技術振興機構 神経細胞特異的な逆行性輸送ベクター
EP3466443B1 (en) 2012-02-14 2020-12-16 Boehringer Ingelheim Animal Health USA Inc. Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
WO2016054079A1 (en) 2014-09-29 2016-04-07 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
CA2966191A1 (en) * 2014-11-03 2016-05-12 Merial, Inc. Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817491A (en) * 1990-09-21 1998-10-06 The Regents Of The University Of California VSV G pseusdotyped retroviral vectors
WO1999061639A2 (en) * 1998-05-22 1999-12-02 Oxford Biomedica (Uk) Limited Retroviral delivery system
US20040076613A1 (en) * 2000-11-03 2004-04-22 Nicholas Mazarakis Vector system
US6818209B1 (en) * 1998-05-22 2004-11-16 Oxford Biomedica (Uk) Limited Retroviral delivery system
EP0961830A1 (en) * 1997-01-29 1999-12-08 Neurosearch A/S EXPRESSION VECTORS AND METHODS FOR $i(IN VIVO) EXPRESSION OF THERAPEUTIC POLYPEPTIDES

Also Published As

Publication number Publication date
EP1333863A2 (en) 2003-08-13
US20040071675A1 (en) 2004-04-15
WO2002036170A2 (en) 2002-05-10
WO2002036170A3 (en) 2002-08-22
JP2004517057A (ja) 2004-06-10
JP2008303215A (ja) 2008-12-18

Similar Documents

Publication Publication Date Title
AU2002218623A1 (en) Robot system
AU2002218627A1 (en) Robot system
AU6607700A (en) Robotic system
AU2001239746A1 (en) Group-browsing system
AUPP971499A0 (en) On-line electoral system
AU4192199A (en) Proposal based architecture system
AU2297001A (en) Telestrator system
AUPQ802400A0 (en) Propulsion system
AU6232800A (en) On-line higher education financing system
AU1335900A (en) Transformation vector system
AU2001232054A1 (en) Vector
AU2495300A (en) Lentivirus vector system
AU2002214132A1 (en) Vector system for transducing the positive neurons
AU2001252758A1 (en) Online relay-broadcasting system
AU2001284775A1 (en) Anti-balling system
AU5216601A (en) Reconnaissance system
AU2001277213A1 (en) High-availability shared-memory system
AU4868201A (en) Tracking system
AU2001289885A1 (en) Air-preparation system
AU2003271883A1 (en) Vector system
AUPQ009199A0 (en) Wetsuit
AU2001285846A1 (en) Learning system
AU7764400A (en) Product verification system
AU2001293667A1 (en) Buckle-fastener system
AU6795501A (en) Modelling system